GRI Bio, Inc. (GRI)
CIK 1824293 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 2.2M shares as of Aug 13, 2026 (10-Q). Share count fell from 8.9M to 525,358 between Nov 13, 2024 and Mar 11, 2025, a pattern consistent with a reverse split (roughly 1-for-17); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Series F Common Stock Warrants | 380,962 | $21 | — | — |
| Warrants Expiring In December2030 One | 380,962 | $21 | — | — |
| Pre Funded Warrants | 287,977 | $0.0028 | — | — |
| Series E1 Common Warrants | 49,605 | not tagged | — | — |
| Series E2 Common Warrants | 49,605 | not tagged | — | — |
| Series E3 Common Warrants | 49,605 | not tagged | — | — |
| Warrants Expiring In October2026 | 49,605 | $89.6 | — | — |
| Warrants Expiring In April2030 One | 49,605 | $89.6 | — | — |
| December2025 PA Warrants | 26,667 | $26.25 | — | — |
| Warrants Expiring In December2030 Two | 26,667 | $26.25 | — | — |
| Warrants Expiring In September2029 | 4,593 | $871.08 | — | — |
| April2025 PA Warrants | 3,474 | $126 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 14, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 167 underlying shares, as reported Jul 31, 2022 (10-K).
Reported exercise price: $0.01 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $18,000 as of Sep 30, 2023.
Rough fully diluted estimate: 2.2M = 2.2M O/S + 167 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 14, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 2.2M | Aug 13, 2026 |
| + Series F Common Stock Warrants (if exercised) | 380,962 | Dec 11, 2025 |
| + Warrants Expiring In December2030 One (if exercised) | 380,962 | Jun 30, 2026 |
| + Pre Funded Warrants (if exercised) | 287,977 | Dec 11, 2025 |
| + Series E1 Common Warrants (if exercised) | 49,605 | Apr 1, 2025 |
| + Series E2 Common Warrants (if exercised) | 49,605 | Apr 1, 2025 |
| + Series E3 Common Warrants (if exercised) | 49,605 | Apr 1, 2025 |
| + Warrants Expiring In October2026 (if exercised) | 49,605 | Jun 30, 2026 |
| + Warrants Expiring In April2030 One (if exercised) | 49,605 | Jun 30, 2026 |
| + December2025 PA Warrants (if exercised) | 26,667 | Dec 11, 2025 |
| + Warrants Expiring In December2030 Two (if exercised) | 26,667 | Jun 30, 2026 |
| + Warrants Expiring In September2029 (if exercised) | 4,593 | Jun 30, 2026 |
| + April2025 PA Warrants (if exercised) | 3,474 | Apr 1, 2025 |
| Fully diluted estimate | 3.5M | +62.2% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $270.9Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 3 executed · 3 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full GRI workspace